Since its inception, SYnAbs has developed a huge track record in leveraging immunoassays in order to meet customers' requirements through all phases of assays development, validation and testing.
SYnAbs'speciality is to develop, transfer and market innovative assays with an array of platforms including:
- ELISA (like unique residual protein A),
- Lateral flow dot (like MYstick mouse isotyping kit),
- Custom immuno-affinity columns,